SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
Embolization continues to be one of the most dynamic and rapidly evolving areas in endovascular care, with expanding indications, novel devices, a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Boston Scientific announced it received FDA 510(k) ...
LONDON--(BUSINESS WIRE)--The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results